626 results on '"Trapani, Dario"'
Search Results
2. Surgical and Oncological Outcomes of Level III–IV Versus Level I–II Inferior Vena Cava Thrombectomy: A Decennial Experience of a High-Volume European Referral Center
3. Integrity matters in oncology: AORTIC takes a stand against research misconduct
4. Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer
5. Premature mortality trends in 183 countries by cancer type, sex, WHO region, and World Bank income level in 2000–19: a retrospective, cross-sectional, population-based study
6. Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials
7. The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer
8. Globalization of clinical research in oncology: Status, challenges, and future directions
9. Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan
10. Mechanisms of Endocrine Resistance in Hormone Receptor-Positive Breast Cancer
11. Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection
12. The Global Landscape on the Access to Cancer Medicines for Breast Cancer: The ONCOLLEGE Experience
13. Next-Generation Sequencing for Advanced Breast Cancer: What the Way to Go?
14. Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates
15. Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
16. GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists
17. Targeting HER2 heterogeneity in breast and gastrointestinal cancers
18. Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems
19. Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center
20. Variant allele frequency: a decision-making tool in precision oncology?
21. The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utility
22. Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations
23. The immunogram of inflammatory breast cancer
24. Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments
25. The role of digital health in supporting cancer patients' mental health and psychological well-being for a better quality of life: A systematic literature review
26. Immunotherapy for inflammatory breast cancer: current evidences and future perspectives
27. Prostate cancer
28. Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study
29. Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases
30. Emerging Targeted Therapies for Early Breast Cancer
31. Challenging cases in high-risk prostate cancer patients treated with Retzius-sparing robot-assisted radical prostatectomy
32. Cardiovascular events in patients receiving immuno-oncology agents, in phase I clinical trials: CAVIO study.
33. Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
34. Global Landscape of the Attack of Predatory Journals in Oncology
35. MP58-03 RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH THE HUGO RAS SYSTEM: FEASIBILITY, OPERATIVE SETUP AND SURGICAL OUTCOMES
36. MP58-06 URINARY CONTINENCE RECOVERY AFTER RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY AND ADJUVANT RADIATION THERAPY
37. MP58-05 RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY FOR LARGE PROSTATE VOLUMES: SURGICAL AND FUNCTIONAL OUTCOMES
38. Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviors
39. Optimizing Postneoadjuvant Treatment in Patients With Early Breast Cancer Achieving Pathologic Complete Response
40. Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward
41. Origins and Pathology of Epithelial Ovarian Cancer: A Brief Overview
42. An Introduction to the Current Management of Ovarian Cancer in the Era of Precision Oncology
43. The Advent of Circulating Tumor DNA in the Management of Ovarian Cancer
44. Inflammatory Breast Cancer
45. Essential medicines list in national cancer control plans: a secondary analysis from a global study
46. Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients
47. Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey
48. Unveiling the Untapped Potential of Antibody Drug Conjugates in Precision Oncology
49. WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all
50. Biomarkers for Antibody–Drug Conjugates in Solid Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.